Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility

Pharmacogenetics. 1993 Dec;3(6):322-7. doi: 10.1097/00008571-199312000-00006.

Authors

E T Buchert¹, R L Woosley, S M Swain, S J Oliver, S S Coughlin, L Pickle, B Trock, A T Riegel

Affiliation

¹ Department of Pharmacology, Georgetown University Medical Center, Washington, DC 20007.

PMID: 8148873
DOI: 10.1097/00008571-199312000-00006

No abstract available

MeSH terms

Adult
Aged
Aged, 80 and over
Base Sequence
Breast Neoplasms / genetics*
Cytochrome P-450 CYP2D6
Cytochrome P-450 Enzyme System / genetics*
DNA Primers
Gene Frequency
Genetic Predisposition to Disease
Genotype
Humans
Male
Middle Aged
Mixed Function Oxygenases / genetics*
Molecular Sequence Data

Substances

DNA Primers
Cytochrome P-450 Enzyme System
Mixed Function Oxygenases
Cytochrome P-450 CYP2D6